Inactive Instrument

Company Generex Biotechnology Corporation OTC Bulletin Board

Equities

US3714851033

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Generex Biotechnology Corporation

Business Summary

Generex Biotechnology Corporation is a life science holding company. The Company is engaged in pharmaceutical and biotechnological research and development and other activities. It is focused on building an organizational platform for the financing, development, commercialization and distribution of promising devices, biologics, therapeutic and diagnostic products to improve human health. The Company's subsidiary includes NuGenerex family of companies: NuGenerex Immuno-Oncology, Inc., NuGenerex Diagnostics, NuGenerex Health, LLC, NuGenerex Regenerative Medicine (NRM), NuGenerex Diagnostics (NGD), and NuGenerex Therapeutics. NuGenerex Immuno-Oncology, Inc. is a platform biotechnology company focused on improving the innate immune system to treat and prevent cancer and infectious disease with a pipeline of immunotherapy indications based on its patented platform technology.

Sales per Business

USD in Million2019Weight2020Weight Delta
Drug Delivery Systems and Technologies
99.3 %
- - 3 99.3 % -
Management Services
0.7 %
- - 0 0.7 % -

Sales per region

USD in Million2019Weight2020Weight Delta
United States
100.0 %
6 100.0 % 3 100.0 % -57.10%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 17-11-20
Director of Finance/CFO - 16-12-31
Chief Operating Officer 65 18-06-24
Chief Investment Officer 54 17-11-20
Chief Administrative Officer 54 18-10-11
Chief Tech/Sci/R&D Officer 43 17-01-31
General Counsel - 19-02-11
Sales & Marketing - 19-01-07
Corporate Officer/Principal - 19-01-07
Corporate Officer/Principal 66 04-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 04-02-29
Corporate Officer/Principal 66 04-12-31
Director/Board Member 57 17-11-20
Chief Executive Officer 61 17-11-20
Chief Investment Officer 54 17-11-20
Director/Board Member 73 19-04-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 122,058,444 122,058,444 ( 100.00 %) 0 100.00 %

Company contact information

Generex Biotechnology Corp.

10102 USA Today Way

33025, Miramar

+416 364 2551

http://www.generex.com
address Generex Biotechnology Corporation
  1. Stock Market
  2. Equities
  3. GNBT Stock
  4. Stock
  5. Company Generex Biotechnology Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW